Latham & Watkins Advises Initial Purchasers in PetIQ, Inc.’s Convertible Senior Notes Offering

Proceeds to be used to fund Capstar acquisition.

May 15, 2020

PetIQ, Inc. (“PetIQ”), a leading pet medication and wellness company, has announced the pricing of its offering of US$125 million aggregate principal amount of 4% convertible senior notes due 2026 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The issuance and sale of the notes are scheduled to settle on May 19, 2020, subject to customary closing conditions. PetIQ also granted the initial purchasers of the notes a 30-day option to purchase up to an additional US$18.75 million principal amount of notes.

Latham & Watkins LLP represented the initial purchasers in the offering with a corporate team led by Chicago partner Christopher Lueking and New York partner Stelios Saffos, with associates Scott Westhoff, Jonathan Burns, and Tina Jeon. Advice was also provided on convertible debt matters by New York partner Greg Rodgers, with counsel Arash Aminian Baghai and associate Ryan Gold; on derivative matters by New York partner Catherine Lee, with associate Jack Neff; and on tax matters by New York partner Bora Bozkurt, with associate Ron Moore.

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.